Profile: SATVI--a Leading Light in Tuberculosis Vaccine Research

Lancet. 2013 Mar 23;381(9871):984. doi: 10.1016/S0140-6736(13)60698-4. Epub 2013 Mar 22.

Publication types

  • News

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • HIV Seronegativity
  • Humans
  • Infant
  • South Africa
  • Tuberculosis / prevention & control*
  • Tuberculosis Vaccines*
  • Viral Vaccines*

Substances

  • MVA 85A
  • Tuberculosis Vaccines
  • Viral Vaccines